10-Q: Benchmark Electronics Reports Steep Profit Decline Amidst Sales Dip and Significant Tax Charges
Quarterly Report
Benchmark Electronics, Inc. reported a substantial decrease in net income and earnings per share for the second quarter and first half of 2025, driven by lower sales and a significant discrete tax expense related to foreign dividend repatriation.
Summary
- Sales for the three months ended June 30, 2025, decreased by 4% to $642.3 million from $665.9 million in the prior year period.
- Sales for the six months ended June 30, 2025, decreased by 5% to $1,274.1 million from $1,341.5 million in the prior year period.
- Net income for the three months ended June 30, 2025, plummeted to $1.0 million ($0.03 per diluted share) from $15.5 million ($0.43 per diluted share) in the same period last year.
- Net income for the six months ended June 30, 2025, was $4.6 million ($0.13 per diluted share), down from $29.5 million ($0.81 per diluted share) in the comparable prior year period.
- Gross profit decreased by 5% for both the three and six months ended June 30, 2025, to $64.8 million and $128.0 million, respectively.
- Income from operations decreased by 25% to $20.5 million for the three months and 39% to $32.2 million for the six months ended June 30, 2025.
- The effective income tax rate surged to 94.1% for the three months and 81.5% for the six months ended June 30, 2025, primarily due to a $10.4 million discrete tax charge from foreign withholding taxes on repatriated dividends and deferred tax liabilities on China unremitted earnings.
- The company repatriated net dividends of $136.4 million from China and Thailand, incurring $15.2 million in withholding taxes.
- Sales to the Advanced Computing and Communications (AC&C) sector decreased significantly by 44% for the quarter and 47% for the six months, primarily due to lower demand and program transitions.
- Sales in the Americas segment decreased by 14% for the quarter and 19% for the six months, mainly due to softness in AC&C and Semi-Cap sectors.
- The company entered into a new $700 million credit agreement on June 27, 2025, consisting of a $550 million revolving credit facility and a $150 million term loan, both maturing on June 27, 2030.
- The company repurchased 0.4 million shares for $16.0 million during the six months ended June 30, 2025, with $133.5 million remaining under share repurchase authorizations.
- Cash dividends paid totaled $12.3 million for the six months ended June 30, 2025, and a quarterly cash dividend of $0.17 per share was declared on June 9, 2025, paid on July 11, 2025.
Sentiment
Score: 3
Explanation: The significant decline in net income and EPS, coupled with overall revenue decrease and a very high effective tax rate due to a discrete charge, indicates a challenging financial period. While some sectors show growth and debt was refinanced, the overall profitability picture is concerning, leading to a negative sentiment.
Positives
- Sales to the Semiconductor Capital Equipment (Semi-Cap) sector increased by 11% for the quarter and 14% for the six months, driven by higher demand and new program wins.
- Sales to the Aerospace and Defense (A&D) sector increased by 16% for both the quarter and six months, reflecting strong market growth.
- Asia segment sales increased by 11% for both the quarter and six months due to increased existing customer demand in Semi-Cap and industrial sectors.
- Europe segment sales increased by 2% for the six months, primarily from higher demand in A&D and Industrial sectors.
- The company successfully refinanced its debt with a new $700 million credit agreement, extending maturities to June 27, 2030.
- Repatriated $136.4 million in net dividends from foreign operations, which were used to reduce outstanding borrowings.
- Maintained compliance with all financial covenants and restrictions under the new credit agreement.
- Continued share repurchase program, buying back $16.0 million in shares during the first half of 2025.
- Continued payment of quarterly cash dividends, demonstrating commitment to shareholder returns.
Negatives
- Net income decreased significantly by 93.7% for the three months and 84.4% for the six months ended June 30, 2025, compared to the prior year.
- Diluted earnings per share dropped from $0.43 to $0.03 for the quarter and from $0.81 to $0.13 for the six months.
- Overall sales decreased by 4% for the quarter and 5% for the six months.
- The effective income tax rate dramatically increased to 94.1% for the quarter and 81.5% for the six months due to a $10.4 million discrete tax charge related to foreign dividend repatriation and deferred tax liabilities on China unremitted earnings.
- Sales to the Advanced Computing and Communications (AC&C) sector saw a substantial decline of 44% for the quarter and 47% for the six months due to demand softness and program transitions.
- Sales to the Medical sector decreased by 2% for the quarter and 6% for the six months, impacted by end-demand weakness and delayed program ramps.
- Americas segment sales decreased significantly by 14% for the quarter and 19% for the six months.
- Income from operations decreased by 25% for the quarter and 39% for the six months, attributed to lower sales, increased SG&A expenses (including stock-based compensation), and higher restructuring charges.
- Incurred $10.7 million in settlement costs related to a tax assessment in the Americas for the six months ended June 30, 2025.
Risks
- Customer demand fluctuations and product obsolescence can adversely affect sales, especially given the concentration of sales to a small number of major customers (53% from top ten customers).
- Supply chain constraints, particularly for older semiconductor technologies, could limit the ability to meet customer demand.
- Continuing inflationary pressures, high interest rates, and geopolitical uncertainties (including hostilities, trade restrictions, and tariffs) create an uncertain economic environment.
- Fluctuations in foreign currency exchange rates pose risks to international operations and financial results.
- The company is exposed to risks associated with operating in developing countries, including potential impacts from natural disasters and slower recovery times.
- The company's future dividend policy is not mandatory or guaranteed and depends on various factors including financial condition, indebtedness, and contractual restrictions.
Future Outlook
Management believes existing cash balances, funds from operations, and borrowing availability under the revolving credit facility will be sufficient to meet liquidity requirements over the next 12 months and in future years. The company expects capital expenditures of $60 million to $70 million over the next 12 months to support anticipated revenue growth and global business. The Board of Directors intends to continue paying quarterly dividends, though future payments are not guaranteed and depend on various financial and operational factors. The company is evaluating the future impact of the recently enacted 'The One Big Beautiful Bill Act of 2025' on its financial statements.
Management Comments
- "We continue to monitor the current economic environment and its potential impact on our business, results of operations or financial condition, as well as potential impact on our end customers whose demand for our products and services may be adversely impacted as a result of changes in policies by the U.S. or other governments, and closely manage our costs and capital resources so that we can respond appropriately as circumstances change."
- "Our estimates may change as new events occur and additional information is obtained. Actual results could differ from these estimates under different assumptions or conditions."
- "The overall revenue decrease was primarily due to lower AC&C revenue, due to general end demand softness. This was partially offset by an increase in Semi-Cap and A&D revenue, due to improving demand and new customer wins."
- "After a period of unprecedented global labor and supply disruptions, we have seen a general easing of certain material constraints across commodity categories, with the exception of older technologies where semiconductor OEMs are not adding incremental capacity."
- "The lack of capacity regarding these older technologies could constrain our ability to produce the full demand forecasts we are receiving from customers needing those parts."
- "We have experienced a significant reduction of non-cancellable and non-returnable business terms from our suppliers as lead times have improved significantly from previous highs."
- "Our people-first culture is centered on our five core values, consisting of acting with integrity, valuing inclusion, commitment to customers, promoting ingenuity, and genuine caring for each other, our customers and our communities, and we take pride in our innovative and continuous improvement mindset."
- "Our intent is to delight our customers while delivering operational and financial performance aligned with our goals."
Industry Context
The company operates in the advanced manufacturing services sector, serving diverse markets including industrial, aerospace and defense, medical, semiconductor capital equipment, and advanced computing and communications. The mixed performance across sectors reflects broader industry trends: strong demand in Semi-Cap and A&D, indicating resilience or growth in those areas, while softness in AC&C and Medical suggests sector-specific challenges or market saturation. The easing of general material constraints aligns with broader supply chain improvements, though specific issues with older semiconductor technologies highlight persistent bottlenecks in certain niche areas. The company's focus on complex products for regulated markets positions it in higher-value segments, potentially offering some insulation from broader economic volatility.
Legal Proceedings
- Benchmark Guadalajara received a tax assessment from the Jalisco, Mexico office of customs and taxing authorities (SAT) asserting approximately $12.0 million in import duties, customs penalties, fees, and surcharges relating to goods imported in Q1 2016. This was challenged and an agreement was reached to reduce the amount to approximately $10.1 million, which the company accrued. An additional $0.6 million of other related costs were incurred in Q2 2025. The company plans to pursue reimbursement opportunities.
Stakeholder Impact
- Shareholders: Experienced a significant decrease in earnings per share and net income, but the company continued its share repurchase program and quarterly dividend payments.
- Employees: Restructuring charges primarily related to capacity and workforce reductions at sites in the Americas, indicating potential job impacts.
- Customers: Some customers experienced demand softness (AC&C, Medical) and delayed program ramps, while others saw improving demand and new program wins (Semi-Cap, A&D). Supply chain constraints for older technologies could impact product availability.
- Creditors: The company successfully refinanced its debt, extending maturities and maintaining compliance with all financial covenants, which is positive for creditors.
- Suppliers: Easing of certain material constraints and reduction of non-cancellable/non-returnable business terms from suppliers indicate a more favorable environment for the company, but older technology constraints persist.
Next Steps
- Continue evaluating the guidance and impact of ASU 2023-09 (Improvements to Income Tax Disclosures) on financial statements.
- Continue evaluating the guidance and impact of ASU 2024-03 (Disaggregation of Income Statement Expenses) on financial statements.
- Benchmark Guadalajara plans to continue pursuing all available reimbursement opportunities pertaining to the $10.1 million tax assessment.
- Continue implementing upgrades to the ERP system in phases at remaining locations over the next several years, assessing the impact on internal control over financial reporting.
- Monitor the current economic environment and its potential impact on business, results of operations, and financial condition.
- Closely manage costs and capital resources to respond to changing circumstances.
- Evaluate the future impact of 'The One Big Beautiful Bill Act of 2025' on financial statements.
- Quarterly installments of 0.625% of the initial aggregate term loan advances under the new credit agreement will begin on September 30, 2025.
Key Dates
| Date | Description |
|---|---|
| February 19, 2020 | Board of Directors approved an expanded share repurchase authorization of up to $150 million. |
| December 21, 2021 | Date of the company's previous amended and restated credit agreement. |
| February 3, 2023 | Date of Amendment No. 2 to the previous credit agreement. |
| July 20, 2023 | Company entered into an interest rate swap agreement. |
| December 2023 | FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740), effective for annual periods beginning after December 15, 2024. |
| January 1, 2024 | Retroactive effective date of China tax holiday reducing statutory tax rate from 25% to 15%. |
| December 31, 2024 | End of the previous fiscal year for which the 10-K was filed. |
| November 2024 | FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40), effective for annual periods beginning after December 15, 2026. |
| January 7, 2025 | Benchmark Guadalajara received a tax assessment from Jalisco, Mexico office of customs and taxing authorities. |
| February 19, 2025 | Benchmark Guadalajara challenged the tax assessment by taking an administrative appeal with the SAT. |
| April 2025 | Benchmark Guadalajara and SAT reached an agreement to reduce the tax assessment amount to approximately $10.1 million. The company also fully paid its remaining transition tax liability of $20.1 million from the U.S. Tax Cuts and Jobs Act. |
| June 9, 2025 | Company declared a quarterly cash dividend of $0.17 per share. |
| June 27, 2025 | Company entered into a new $700 million second amended and restated credit agreement, with a maturity date of June 27, 2030. |
| June 30, 2025 | End of the quarterly period covered by this report. Record date for the declared quarterly dividend. |
| July 4, 2025 | U.S. government enacted The One Big Beautiful Bill Act of 2025, including changes to corporate income tax system. |
| July 11, 2025 | Payment date for the quarterly dividend declared on June 9, 2025. |
| July 29, 2025 | Date of common stock outstanding count (35,910,705 shares). |
| July 31, 2025 | Date the Form 10-Q was signed and filed. |
| September 30, 2025 | Beginning date for quarterly installments of 0.625% of the initial aggregate term loan advances under the new credit agreement. |
| December 31, 2026 | Expiration date of the China tax holiday. |
| June 30, 2028 | End date for quarterly installments of 0.625% of the initial aggregate term loan advances under the new credit agreement. |
| December 31, 2030 | Expiration date of tax incentives in Thailand. |
Recommendation
sellThe significant decline in net income and EPS, coupled with a substantial increase in the effective tax rate due to a discrete charge, points to a challenging financial performance. While some segments show growth and debt was refinanced, the overall profitability and operational income are down. The high tax rate, even if partially non-recurring, severely impacts the bottom line. The softness in key sectors like AC&C and Medical, along with ongoing restructuring charges and a tax settlement, suggest underlying operational headwinds. Given the sharp drop in profitability and the mixed revenue performance, a seasoned investor would likely consider selling or reducing their position until a clear path to sustained earnings recovery is demonstrated.
Keywords
Electronics Manufacturing Services, Advanced Manufacturing, Semiconductor Capital Equipment, Aerospace and Defense, Medical Devices, Industrial, Advanced Computing and Communications, Supply Chain Management, SEC Filing, 10-Q, Financial Results, Dividend Repatriation, Debt Refinancing, Share Repurchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.